Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	COVID-19: Daily Top 10 Papers

Colorectal Neoplasms

Free Subscription Articles published in Anticancer Res Retrieve available abstracts of 101 articles: HTML format

Single Articles

October 2021
1. SATO S, Shiozawa M, Nukada S, Iguchi K, et al
   Preoperative Pre-albumin Concentration as a Predictor of Short-term Outcomes in Elderly Patients With Colorectal Cancer.
   Anticancer Res. 2021;41:5195-5202.
   PubMed     Abstract available
   
   
   
2. ATSUMI Y, Numata M, Kazama K, Kawahara S, et al
   Can D3 Lymph Node Dissection for Patients With Colon Cancer With a Poor C-Reactive Protein/Albumin Ratio Improve Survival Outcomes?
   Anticancer Res. 2021;41:5097-5106.
   PubMed     Abstract available
   
   
   
3. MEKLIN J, Eskelinen M, Guimaraes DP, Selander T, et al
   The New Generation Immunochemical Test for Fecal Occult Blood (ColonView Quick Test) Shows a High Diagnostic Accuracy in Colorectal Cancer Detection.
   Anticancer Res. 2021;41:5071-5079.
   PubMed     Abstract available
   
   
   
4. NEUPANE P, Mimura K, Nakajima S, Okayama H, et al
   The Expression of Immune Checkpoint Receptors and Ligands in the Colorectal Cancer Tumor Microenvironment.
   Anticancer Res. 2021;41:4895-4905.
   PubMed     Abstract available
   
   
   
5. TADA Y, Matsumi Y, Hara K, Miyauchi W, et al
   Infiltration of CD204-overexpressing Macrophages Contributes to the Progression of Stage II and III Colorectal Cancer.
   Anticancer Res. 2021;41:4857-4865.
   PubMed     Abstract available
   
   
   
6. MIYAMOTO S, Fukui T, Horitani S, Tanimura Y, et al
   Linker Threonine-phosphorylated Smad2/3 Is a Biomarker of Colorectal Neoplastic Stem-like Cells that Correlates With Carcinogenesis.
   Anticancer Res. 2021;41:4789-4799.
   PubMed     Abstract available
   
   
   
7. OZLUK E, Coppola D, Mohammad IZ, Islam T, et al
   Ethylmalonic Encephalopathy 1 Protein Is Increased in Colorectal Adenocarcinoma.
   Anticancer Res. 2021;41:4719-4723.
   PubMed     Abstract available
   
   
   
8. SATO K, Miura T, Sakamoto Y, Morohashi H, et al
   Fascial Organisation and Lymphatic Systems Around the Pelvic Floor: A Literature Review.
   Anticancer Res. 2021;41:4705-4714.
   PubMed     Abstract available
   
   
   
9. IIDA T, Murono K, Shiratori H, Nozawa H, et al
   Impact of Inferior Mesenteric Artery Occlusion on the Calibre of Collateral Arteries of the Colon.
   Anticancer Res. 2021;41:5189-5193.
   PubMed     Abstract available
   
   
   
10. CHUNG YC, Ku YL, Chiang HC, Liu WC, et al
    Antibody to Interleukin-6 Receptor Inhibits In Vivo Growth of Human Colorectal Carcinoma Cell Xenografts.
    Anticancer Res. 2021;41:4907-4916.
    PubMed     Abstract available
    
    
    September 2021
11. KIM CW, Ha YJ, Tak KH, Roh SA, et al
    Clinically Applicable Serum Biomarkers Among 14 Candidates Associated With Recurrence of Stage II and III Colorectal Cancer.
    Anticancer Res. 2021;41:4651-4658.
    PubMed     Abstract available
    
    
    
12. KIM HB, Lee SB, Kim SJ, Lee HJ, et al
    Jagged-1 Expression Level Is Correlated With Recurrence of Stage III Colorectal Cancer in Patients Receiving Adjuvant Chemotherapy.
    Anticancer Res. 2021;41:4645-4650.
    PubMed     Abstract available
    
    
    
13. MAZAKI J, Katsumata K, Ohno Y, Udo R, et al
    A Novel Prediction Model for Colon Cancer Recurrence Using Auto-artificial Intelligence.
    Anticancer Res. 2021;41:4629-4636.
    PubMed     Abstract available
    
    
    
14. SHIBUTANI M, Maeda K, Kashiwagi S, Hirakawa K, et al
    The Impact of Intraoperative Blood Loss on the Survival After Laparoscopic Surgery for Colorectal Cancer.
    Anticancer Res. 2021;41:4529-4534.
    PubMed     Abstract available
    
    
    
15. KIM HK, Yang Y, Byeon S, Jeong Y, et al
    E-Cadherin and Angiopoietin-2 as Potential Biomarkers for Colorectal Cancer With Peritoneal Carcinomatosis.
    Anticancer Res. 2021;41:4497-4504.
    PubMed     Abstract available
    
    
    
16. NAGASAWA S, Tsuchida K, Shiozawa M, Hiroshima Y, et al
    Clinical Significance of Chemokine Receptor CXCR4 and CCR7 mRNA Expression in Patients With Colorectal Cancer.
    Anticancer Res. 2021;41:4489-4495.
    PubMed     Abstract available
    
    
    
17. MAZAKI J, Katsumata K, Sujino H, Udo R, et al
    Neutrophil-to-lymphocyte Ratio as a Prognostic Factor for Colon Cancer in Elderly Patients: A Propensity Score Analysis.
    Anticancer Res. 2021;41:4471-4478.
    PubMed     Abstract available
    
    
    
18. SHIBUTANI M, Nakao S, Maeda K, Nagahara H, et al
    The Impact of Tumor-associated Macrophages on Chemoresistance via Angiogenesis in Colorectal Cancer.
    Anticancer Res. 2021;41:4447-4453.
    PubMed     Abstract available
    
    
    
19. SHIN MW, Kim SL, Yang HC, Yim SK, et al
    The HDAC1 Inhibitor CBUD-1001 Enhances TRAIL-induced Apoptosis in Colorectal Cancer Cells.
    Anticancer Res. 2021;41:4353-4364.
    PubMed     Abstract available
    
    
    
20. KOYAMA M, Osada E, Takemura Y, Saito H, et al
    Gelatin Sponge as an Anchorage for Three-dimensional Culture of Colorectal Cancer Cells.
    Anticancer Res. 2021;41:4259-4269.
    PubMed     Abstract available
    
    
    
21. TOKUDA K, Morine Y, Miyazaki K, Yamada S, et al
    Frailty Can Predict Prognosis After Hepatectomy in Patients With Colorectal Liver Metastasis.
    Anticancer Res. 2021;41:4637-4644.
    PubMed     Abstract available
    
    
    
22. OKAMOTO H, Shiba S, Iino H, Sudoh M, et al
    Tumor Vascular Microenvironment of Colorectal Hepatic Metastasis and Chemotherapy Response.
    Anticancer Res. 2021;41:4505-4513.
    PubMed     Abstract available
    
    
    
23. RADES D, Kopelke S, Bartscht T, Schild SE, et al
    Evaluation of Pre-radiotherapy Sleep Disorders in Patients With Rectal or Anal Cancer.
    Anticancer Res. 2021;41:4439-4442.
    PubMed     Abstract available
    
    
    August 2021
24. SATO T, Osumi H, Shinozaki E, Ooki A, et al
    Clinical Impact of Primary Tumor Location and RAS, BRAF V600E, and PIK3CA Mutations on Epidermal Growth Factor Receptor Inhibitor Efficacy as Third-line Chemotherapy for Metastatic Colorectal Cancer.
    Anticancer Res. 2021;41:3905-3915.
    PubMed     Abstract available
    
    
    
25. HASHIMOTO S, Nagai M, Nishi K, Ishikura S, et al
    Growth Suppression of Cancer Spheroids With Mutated KRAS by Low-toxicity Compounds from Natural Products.
    Anticancer Res. 2021;41:4061-4070.
    PubMed     Abstract available
    
    
    
26. JANG BS, Song C, Kang SB, Kim JS, et al
    Radiogenomic and Deep Learning Network Approaches to Predict KRAS Mutation from Radiotherapy Plan CT.
    Anticancer Res. 2021;41:3969-3976.
    PubMed     Abstract available
    
    
    
27. CAO W, Wang Q, Huang C
    Let-7a Inhibits Tumor Metastasis by Regulating TGF-beta/Smad Signaling in the Colorectal Adenocarcinoma Cell Line LS-174T.
    Anticancer Res. 2021;41:3801-3808.
    PubMed     Abstract available
    
    
    July 2021
28. KIM J, Baek DW, Baek JH, Kang BW, et al
    Clinical Impact of Postoperative Vitamin D Deficiency on the Recurrence of Colon Cancer After Curative Surgical Resection.
    Anticancer Res. 2021;41:3683-3688.
    PubMed     Abstract available
    
    
    
29. KUBO H, Ikoma H, Yamamoto Y, Morimura R, et al
    Therapeutic Strategy of Colorectal Liver Metastasis Using Modified-JHBPS Nomogram.
    Anticancer Res. 2021;41:3657-3665.
    PubMed     Abstract available
    
    
    
30. SHIBUTANI M, Maeda K, Kashiwagi S, Hirakawa K, et al
    Effect of Adjuvant Chemotherapy on Survival of Elderly Patients With Stage III Colorectal Cancer.
    Anticancer Res. 2021;41:3615-3624.
    PubMed     Abstract available
    
    
    
31. HIROSHIMA Y, Ishikawa H, Murakami M, Nakamura M, et al
    Proton Beam Therapy for Local Recurrence of Rectal Cancer.
    Anticancer Res. 2021;41:3589-3595.
    PubMed     Abstract available
    
    
    
32. CHEN IY, Findeis-Hosey JJ, Cannon L, Liao X, et al
    Primary Colonic Medullary Carcinoma With Exclusive Squamous Differentiation.
    Anticancer Res. 2021;41:3567-3572.
    PubMed     Abstract available
    
    
    
33. SHIBUTANI M, Maeda K, Kashiwagi S, Nagahara H, et al
    Lactate Dehydrogenase Is a Useful Marker for Predicting the Efficacy of Bevacizumab-containing Chemotherapy in Patients With Metastatic Colorectal Cancer.
    Anticancer Res. 2021;41:3535-3542.
    PubMed     Abstract available
    
    
    
34. RUBIO CA, Schmidt PT
    Crypts in Asymmetric Fission in Endoscopic Biopsies from Swedish Patients With Inflammatory Bowel Disease.
    Anticancer Res. 2021;41:3511-3517.
    PubMed     Abstract available
    
    
    
35. LIM JH, Go G, Lee SH
    PrPC Regulates the Cancer Stem Cell Properties via Interaction With c-Met in Colorectal Cancer Cells.
    Anticancer Res. 2021;41:3459-3470.
    PubMed     Abstract available
    
    
    
36. MATSUI H, Homma S, Hatanaka KC, Sawada A, et al
    Novel Prognostic Stratification Factor Based on the Pathological Profile of the Invasive Front in Colorectal Cancer.
    Anticancer Res. 2021;41:3429-3438.
    PubMed     Abstract available
    
    
    
37. DE ANGELIS PM, Dorg L, Pham S, Andersen SN, et al
    DNA Repair Protein Expression and Oxidative/Nitrosative Stress in Ulcerative Colitis and Sporadic Colorectal Cancer.
    Anticancer Res. 2021;41:3261-3270.
    PubMed     Abstract available
    
    
    June 2021
38. KURAMOCHI H, Yamada T, Yoshida Y, Matsuda A, et al
    The Pre-treatment Lymphocyte-to-Monocyte Ratio Predicts Efficacy in Metastatic Colorectal Cancer Treated With TAS-102 and Bevacizumab.
    Anticancer Res. 2021;41:3131-3137.
    PubMed     Abstract available
    
    
    
39. KIMURA M, Usami E, Teramachi H, Yoshimura T, et al
    Risk-benefit Analysis of FOLFIRI Plus Ramucirumab/Aflibercept as a Third-line Treatment in Metastatic Colorectal Cancer.
    Anticancer Res. 2021;41:3091-3097.
    PubMed     Abstract available
    
    
    
40. KEENAN BP, VAN Loon K, Khilnani AD, Fidelman N, et al
    Molecular and Radiological Features of Microsatellite Stable Colorectal Cancer Cases With Dramatic Responses to Immunotherapy.
    Anticancer Res. 2021;41:2985-2992.
    PubMed     Abstract available
    
    
    
41. DE FELICE F, Fallarino A, Iafrate F, Maiuri V, et al
    The INCH Trial - Induction Chemotherapy in Patients With Bulky Anal Canal Cancer: Evaluation of the Pilot Phase.
    Anticancer Res. 2021;41:3187-3191.
    PubMed     Abstract available
    
    
    
42. SHIRAISHI T, Ogawa H, Kumasaka S, Shimoda Y, et al
    Comparison of Risk Factors for Locally Advanced Lower Rectal Cancer Recurrence Evaluated by Magnetic Resonance Imaging and Pathological Factors Analysed by Longitudinal Slicing Method.
    Anticancer Res. 2021;41:3169-3178.
    PubMed     Abstract available
    
    
    May 2021
43. SUGITA A, Ikeuchi H, Funayama Y, Futami K, et al
    Postoperative Survival in Colitis-associated Colorectal Cancer With Ulcerative Colitis in Japan: A Multicenter Analysis.
    Anticancer Res. 2021;41:2681-2688.
    PubMed     Abstract available
    
    
    
44. TAKAHASHI M, Sakamoto K, Irie T, Kawano S, et al
    Laparoscopic Surgery Is Acceptable for Elderly Patients With Colorectal Cancer: A Propensity Score-matched Study.
    Anticancer Res. 2021;41:2611-2615.
    PubMed     Abstract available
    
    
    
45. SIGNORELLI C, Gemma D, Grande R, DE Marco S, et al
    Regorafenib-to-trifluridine/tipiracil Versus the Reverse Sequence for Refractory Metastatic Colorectal Cancer Patients: A Multicenter Retrospective Real-life Experience.
    Anticancer Res. 2021;41:2553-2561.
    PubMed     Abstract available
    
    
    
46. TAKABATAKE K, Arita T, Nakanishi M, Kuriu Y, et al
    Impact of Inferior Mesenteric Artery Lymph Node Metastasis on the Prognosis of Left-sided Colorectal Cancer.
    Anticancer Res. 2021;41:2533-2542.
    PubMed     Abstract available
    
    
    
47. KITAMURA C, Sonoda H, Anzai H, Nagai Y, et al
    Expression of Lysophosphatidylinositol Signaling-relevant Molecules in Colorectal Cancer.
    Anticancer Res. 2021;41:2349-2355.
    PubMed     Abstract available
    
    
    
48. NUMATA M, Tamagawa H, Kazama K, Atsumi Y, et al
    Potential Benefits of Minimally Invasive Laparoscopy in Reducing Local Recurrence After Surgery for Low Rectal Cancer.
    Anticancer Res. 2021;41:2617-2623.
    PubMed     Abstract available
    
    
    
49. SHIBUTANI M, Kimura K, Kashiwagi S, Wang EN, et al
    Elevated Postoperative Levels of Serum C-reactive Protein Are Associated With Shorter Long-term Survival After Resection of Colorectal Liver Metastases, Regardless of the Occurrence of Infectious Complications.
    Anticancer Res. 2021;41:2605-2610.
    PubMed     Abstract available
    
    
    
50. ELLIOT AH, Othman BN, Suzuki C, Blomqvist L, et al
    Pretreatment MRI in Primary Rectal Cancer as a Predictor for Oncological Outcomes After Surgery for Local Recurrence.
    Anticancer Res. 2021;41:2459-2465.
    PubMed     Abstract available
    
    
    
51. NORZ D, Mullins CS, Smit DJ, Linnebacher M, et al
    Combined Targeting of AKT and mTOR Synergistically Inhibits Formation of Primary Colorectal Carcinoma Tumouroids In Vitro: A 3D Tumour Model for Pre-therapeutic Drug Screening.
    Anticancer Res. 2021;41:2257-2275.
    PubMed     Abstract available
    
    
    April 2021
52. NIISATO Y, Moriwaki T, Fukuoka S, Masuishi T, et al
    Clinical Outcomes Following Trifluridine/Tipiracil Treatment for Patients With Metastatic Colorectal Cancer Ineligible for Regorafenib Treatment.
    Anticancer Res. 2021;41:2203-2207.
    PubMed     Abstract available
    
    
    
53. ISHIZAKI T, Mazaki J, Enomoto M, Shigoka M, et al
    Prospective Multicenter Phase II Study of Biweekly TAS-102 and Bevacizumab for Metastatic Colorectal Cancer.
    Anticancer Res. 2021;41:2157-2163.
    PubMed     Abstract available
    
    
    
54. WATANABE T, Shiozawa M, Kimura Y, Hiroshima Y, et al
    Clinical Significance of Stanniocalcin2 mRNA Expression in Patients With Colorectal Cancer.
    Anticancer Res. 2021;41:2117-2122.
    PubMed     Abstract available
    
    
    
55. SHIBA S, Shibuya K, Okamoto M, Okano N, et al
    Carbon-ion Radiotherapy for Oligometastatic Colorectal Cancer in the Liver or Lung.
    Anticancer Res. 2021;41:1997-2005.
    PubMed     Abstract available
    
    
    
56. NISHINO H, Okuno M, Seo S, Toda R, et al
    Sinusoidal Obstruction Syndrome Promotes Liver Metastatic Seeding of Colorectal Cancer Cells in a Rat Model.
    Anticancer Res. 2021;41:1803-1810.
    PubMed     Abstract available
    
    
    
57. MAEDA T, Konishi H, Takaki W, Takabatake K, et al
    Significance of Plasma UCA1 for Predicting Colorectal Cancer and BRAF Mutation Status.
    Anticancer Res. 2021;41:1761-1769.
    PubMed     Abstract available
    
    
    
58. CARAVATTA L, Lupattelli M, Mantello G, Gambacorta MA, et al
    Treatment Volume, Dose Prescription and Delivery Techniques for Dose-intensification in Rectal Cancer: A National Survey.
    Anticancer Res. 2021;41:1985-1995.
    PubMed     Abstract available
    
    
    
59. FIORI E, Crocetti D, Sapienza P, Miccini M, et al
    Colon or Rectal Stent Positioning for Advanced Cancer Influences Quality of Life: A Critical Point of View.
    Anticancer Res. 2021;41:1945-1950.
    PubMed     Abstract available
    
    
    March 2021
60. SHIBUTANI M, En W, Okazaki Y, Maeda K, et al
    A High Postoperative Serum C-reactive Protein Level Has a Negative Impact on Long-term Survival, Regardless of Postoperative Infectious Complications, in Patients Who Undergo Laparoscopic Surgery for Colorectal Cancer.
    Anticancer Res. 2021;41:1593-1598.
    PubMed     Abstract available
    
    
    
61. PACZEK S, Lukaszewicz-Zajac M, Gryko M, Kulczynska-Przybik A, et al
    The Clinical Utility of Serum CXCR-2 Assessment in Colorectal Cancer (CRC) Patients.
    Anticancer Res. 2021;41:1421-1428.
    PubMed     Abstract available
    
    
    
62. MO S, Ku HJ, Choi SH, Jeong HJ, et al
    470 nm LED Irradiation Inhibits the Invasiveness of CD133-positive Human Colorectal Cancer Stem Cells by Suppressing the Cyclooxygenase-2/prostaglandin E2 Pathway.
    Anticancer Res. 2021;41:1407-1420.
    PubMed     Abstract available
    
    
    
63. TERASAKI M, Hamoya T, Kubota A, Kojima H, et al
    Fucoxanthin Prevents Colorectal Cancer Development in Dextran Sodium Sulfate-treated Apc (Min/+) Mice.
    Anticancer Res. 2021;41:1299-1305.
    PubMed     Abstract available
    
    
    
64. ASADA Y, Tsuruta M, Okabayashi K, Shigeta K, et al
    Inhibition of Heat-shock Protein 27 Reduces 5-Fluorouracil-acquired Resistance in Human Colon Cancer Cells.
    Anticancer Res. 2021;41:1283-1290.
    PubMed     Abstract available
    
    
    
65. WANG S, Wang X, Wang YU, Leng Q, et al
    The Anti-oxidant Monoterpene p-Cymene Reduced the Occurrence of Colorectal Cancer in a Hyperlipidemia Rat Model by Reducing Oxidative Stress and Expression of Inflammatory Cytokines.
    Anticancer Res. 2021;41:1213-1218.
    PubMed     Abstract available
    
    
    
66. AGAWA K, Matsuda T, Yamashita K, Hasegawa H, et al
    Feasibility and Safety of Lateral Pelvic Lymph Node Dissection After Neoadjuvant Chemoradiotherapy for Elderly Patients With Locally Advanced Rectal Cancer.
    Anticancer Res. 2021;41:1677-1682.
    PubMed     Abstract available
    
    
    
67. HIROSE Y, Sakata J, Kobayashi T, Miura K, et al
    NQO1 as a Marker of Chemosensitivity and Prognosis for Colorectal Liver Metastasis.
    Anticancer Res. 2021;41:1563-1570.
    PubMed     Abstract available
    
    
    
68. RUBIO CA, Schmidt PT
    Nondysplastic Crypts in Fission in Nonpolypoid Adenomas and in the Adjacent Mucosa Support Field Cancerization in the Colon.
    Anticancer Res. 2021;41:1515-1521.
    PubMed     Abstract available
    
    
    
69. FINDLEN UM, Belt RL, Fan L, Bridges N, et al
    Hearing Status of Children and Adolescents With Familial Adenomatous Polyposis.
    Anticancer Res. 2021;41:1439-1444.
    PubMed     Abstract available
    
    
    
70. TOKUDA A, Miyake T, Yasukawa D, Ikuta D, et al
    Cancer-derived Exosomes Activate Immune Surveillance and Suppress Peritoneal Metastasis of Murine Colonic Cancer.
    Anticancer Res. 2021;41:1327-1339.
    PubMed     Abstract available
    
    
    February 2021
71. PIAN G, Shin JS, Yoon S, Oh SY, et al
    Prognostic Reappraisal of Postoperative Carcinoembryonic Antigen in T1-2N0 Colorectal Cancer.
    Anticancer Res. 2021;41:1101-1110.
    PubMed     Abstract available
    
    
    
72. KOSUMI K, Mima K, Morito A, Yumoto S, et al
    Patient Age and Long-term Survival in Colorectal Cancer Patients Who Undergo Emergency Surgery.
    Anticancer Res. 2021;41:1069-1076.
    PubMed     Abstract available
    
    
    
73. NAKASHIMA M, Takeuchi M, Tanaka S, Kawakami K, et al
    Salvage Therapy After Regorafenib or Trifluridine/Tipiracil Treatment of Metastatic Colorectal Cancer: A Conditional Landmark Analysis.
    Anticancer Res. 2021;41:1055-1062.
    PubMed     Abstract available
    
    
    
74. OBARA N, Hirano Y, Ishii T, Kondo H, et al
    Laparoscopic Surgery for Colorectal Cancer in Patients on Hemodialysis: A Propensity Score-matched Analysis.
    Anticancer Res. 2021;41:993-997.
    PubMed     Abstract available
    
    
    
75. NAKAMURA M, Kageyama SI, Seki M, Suzuki A, et al
    Liquid Biopsy Cell-free DNA Biomarkers in Patients With Oligometastatic Colorectal Cancer Treated by Ablative Radiotherapy.
    Anticancer Res. 2021;41:829-834.
    PubMed     Abstract available
    
    
    
76. PAPADIMITRIOU M, Papadimitriou CA
    Antiangiogenic Tyrosine Kinase Inhibitors in Metastatic Colorectal Cancer: Focusing on Regorafenib.
    Anticancer Res. 2021;41:567-582.
    PubMed     Abstract available
    
    
    January 2021
77. HUANG RH, Yang WK, Wu CM, Yeh CM, et al
    Over-expression of CEP55 Predicts Favorable Prognosis in Colorectal Cancer Patients With Lymph Node Involvement.
    Anticancer Res. 2021;41:543-547.
    PubMed     Abstract available
    
    
    
78. YAMADA Y, Matsuhashi N, Fujii H, Makiyama A, et al
    Impact of Anti-angiogenic Agents on Chemotherapy Efficacy in Patients With Metastatic Colorectal Cancer: Second-line FOLFIRI Plus Bevacizumab or Aflibercept.
    Anticancer Res. 2021;41:533-541.
    PubMed     Abstract available
    
    
    
79. PODGORSKA M, Pietraszek-Gremplewicz K, OlszaNska J, Nowak D, et al
    The Role of Apelin and Apelin Receptor Expression in Migration and Invasiveness of Colon Cancer Cells.
    Anticancer Res. 2021;41:151-161.
    PubMed     Abstract available
    
    
    
80. THADI A, Morano WF, Khalili M, Babcock BD, et al
    Molecular Targeting of H/MDM-2 Oncoprotein in Human Colon Cancer Cells and Stem-like Colonic Epithelial-derived Progenitor Cells.
    Anticancer Res. 2021;41:27-42.
    PubMed     Abstract available
    
    
    
81. SCHEIPNER L, Smolle MA, Barth D, Posch F, et al
    The AST/ALT Ratio Is an Independent Prognostic Marker for Disease-free Survival in Stage II and III Colorectal Carcinoma.
    Anticancer Res. 2021;41:429-436.
    PubMed     Abstract available
    
    
    December 2020
82. KIMURA M, Usami E, Yoshimura T
    Effects of Type of Antibody to EGFR and Hypomagnesemia on Overall Survival in First-line Treatment of Patients With Unresectable Advanced/Recurrent Colorectal Cancer.
    Anticancer Res. 2020;40:7135-7140.
    PubMed     Abstract available
    
    
    
83. AHMED A, Halama N
    Differential Analyses of Peripheral Blood Parameters in CCR5 Inhibition-treated Colorectal Cancer Patients Reveal Dynamic Changes Linked to Clinical Outcomes.
    Anticancer Res. 2020;40:6933-6939.
    PubMed     Abstract available
    
    
    
84. ANNICCHIARICO A, Morini A, Romboli A, RiccO M, et al
    Stage III and Metastatic Lymph Node Ratio Are the only Independent Prognostic Factors in Colorectal Signet-ring Cell Carcinoma Patients.
    Anticancer Res. 2020;40:7127-7134.
    PubMed     Abstract available
    
    
    
85. LIU B, Shiraga S, Mortenson MM, Lai J, et al
    Small Cell Lung Carcinoma and Synchronous Rectal Adenocarcinoma and Jejunal Gastrointestinal Stromal Tumor Present in a Patient With History of Laryngeal Squamous Cell Carcinoma.
    Anticancer Res. 2020;40:7053-7056.
    PubMed     Abstract available
    
    
    
86. VODICKA J, Fichtl J, Sebek J, ProchAzkovA K, et al
    Outcomes and Prognostic Factors Following Surgical Treatment of Pulmonary Metastases from Colorectal Carcinoma.
    Anticancer Res. 2020;40:7045-7051.
    PubMed     Abstract available
    
    
    
87. YAMAMOTO J, Sugisawa N, Hamada K, Nishino H, et al
    A Universal Gelfoam 3-D Histoculture Method to Establish Patient-derived Cancer Cells (3D-PDCC) Without Fibroblasts from Patient-derived Xenografts.
    Anticancer Res. 2020;40:6765-6768.
    PubMed     Abstract available
    
    
    
88. PALEK R, Rosendorf J, Maleckova A, Vistejnova L, et al
    Influence of Mesenchymal Stem Cell Administration on The Outcome of Partial Liver Resection in a Porcine Model of Sinusoidal Obstruction Syndrome.
    Anticancer Res. 2020;40:6817-6833.
    PubMed     Abstract available
    
    
    November 2020
89. AHMED A, Halama N
    Tertiary Lymphoid Structures in Colorectal Cancer Liver Metastases: Association With Immunological and Clinical Parameters and Chemotherapy Response.
    Anticancer Res. 2020;40:6367-6373.
    PubMed     Abstract available
    
    
    
90. NGAMKHAM J, Thuwajit C, Thuwajit P, Khamwachirapithak P, et al
    Overexpression of Pyruvate Carboxylase Is Correlated With Colorectal Cancer Progression and Supports Growth of Invasive Colon Cancer HT-29 Cell Line.
    Anticancer Res. 2020;40:6285-6293.
    PubMed     Abstract available
    
    
    
91. LIN PM, Lee HM, Huang CI, Tai TS, et al
    Synergistic Antiproliferative Effect of Ribociclib (LEE011) and 5-Fluorouracil on Human Colorectal Cancer.
    Anticancer Res. 2020;40:6265-6271.
    PubMed     Abstract available
    
    
    
92. MUSA M, Ouaret D, Bodmer WF
    In Vitro Analyses of Interactions Between Colonic Myofibroblasts and Colorectal Cancer Cells for Anticancer Study.
    Anticancer Res. 2020;40:6063-6073.
    PubMed     Abstract available
    
    
    
93. NAGATA M, Matsuda T, Hasegawa H, Utsumi M, et al
    Usefulness of Omentoplasty to Reduce Perineal Wound Complications in Abdominoperineal Resection After Neoadjuvant Chemoradiotherapy.
    Anticancer Res. 2020;40:6539-6543.
    PubMed     Abstract available
    
    
    
94. RYU S, Okamoto A, Nakashima K, Hara K, et al
    Usefulness of Preoperative Endoscopic Fluorescent Clip Marking in Laparoscopic Gastrointestinal Surgery.
    Anticancer Res. 2020;40:6517-6523.
    PubMed     Abstract available
    
    
    
95. HUANG WL, Luo CW, Chou CL, Yang CC, et al
    High Expression of UBE2B as a Poor Prognosis Factor in Patients With Rectal Cancer Following Chemoradiotherapy.
    Anticancer Res. 2020;40:6305-6317.
    PubMed     Abstract available
    
    
    October 2020
96. GO G, Yun CW, Yoon YM, Lim JH, et al
    Role of PrP(C) in Cancer Stem Cell Characteristics and Drug Resistance in Colon Cancer Cells.
    Anticancer Res. 2020;40:5611-5620.
    PubMed     Abstract available
    
    
    
97. YAMADA Y, Yoshimatsu K, Yokomizo H, Okayama S, et al
    Expression of ATP-binding Cassette Transporter 11 (ABCC11) Protein in Colon Cancer.
    Anticancer Res. 2020;40:5405-5409.
    PubMed     Abstract available
    
    
    
98. JONSSON G, Philipson L, Villman K, Valachis A, et al
    Upfront Radiotherapy in Patients With Asymptomatic Incurable Rectal Cancer: A Retrospective Cohort Study.
    Anticancer Res. 2020;40:5853-5860.
    PubMed     Abstract available
    
    
    
99. ANGELOU A, Papalois AE, Antoniou E, Wang J, et al
    The Interplay Between Innate Immunity (TLR-4) and sCD40L in the Context of an Animal Model of Colitis-associated Cancer.
    Anticancer Res. 2020;40:5457-5462.
    PubMed     Abstract available
    
    
    
100. YIN F, Xie H, Lai J, Chen Y, et al
     Double Negativity for Expression of YAP1 and CDX2 Defines an Aggressive Type of Colitis-associated Cancer.
     Anticancer Res. 2020;40:5411-5416.
     PubMed     Abstract available
     
     
     
101. JIA JB, Ling X, Xing M, Ludwig JM, et al
     Novel TSPO-targeted Doxorubicin Prodrug for Colorectal Carcinoma Cells.
     Anticancer Res. 2020;40:5371-5378.
     PubMed     Abstract available
     
     

Thank you for your interest in scientific medicine.

AMEDEO Colorectal Neoplasms is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: